Clinical Research Directory

A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada

Sponsor: Bristol-Myers Squibb

Summary

This real-world study will describe the demographic and clinical characteristics and mavacamten treatment of adult patients with obstructive hypertrophic cardiomyopathy who participated in the Bristol-Myers Squibb (BMS)-sponsored CAMZYOS Patient Support Program in Canada.

Official title: Patient Characteristics and Treatment Duration of Mavacamten Obstructive HCM Patient Support Program in Canada: A Retrospective Cohort Study

Key Details

Conditions

Interventions

Locations (1)